PTC Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
PTC Therapeutics announced its participation in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021, at 7:30 a.m. EST. The event will be webcast live, with a replay available for 30 days. The company focuses on developing and commercializing innovative medicines for rare disorders, aiming to improve patient access to necessary treatments. Interested parties are encouraged to join the webcast via the investor relations section on PTC's website.
- None.
- None.
SOUTH PLAINFIELD, N.J., Jan. 4, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11th at 7:30 a.m. EST.
The presentation will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at www.ptcbio.com and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.
About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.
FOR MORE INFORMATION PLEASE CONTACT:
Media & Investors:
Jane Baj
+1 (908) 912-9167
jbaj@ptcbio.com
View original content:http://www.prnewswire.com/news-releases/ptc-therapeutics-to-present-at-the-39th-annual-jp-morgan-healthcare-conference-301198727.html
SOURCE PTC Therapeutics, Inc.
FAQ
When will PTC Therapeutics present at the J.P. Morgan Healthcare Conference?
How can I watch the PTC Therapeutics presentation at the conference?
What is the focus of PTC Therapeutics?